LYC-55716 targets and inhibits the activity of the RAR-related orphan receptors, which are nuclear receptors involved in the regulation of various biological processes including immune response, circadian rhythm, and metabolism.
Molecular Weight
603.53
Molecular Formula
C27H23F6NO6S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
LYC-55716 is a ROR inhibitor, studied for its potential in cancer immunotherapy and autoimmune disease management.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
